Compare CORT & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | VLY |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.1B |
| IPO Year | 2001 | 1994 |
| Metric | CORT | VLY |
|---|---|---|
| Price | $113.79 | $13.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $96.50 | $14.65 |
| AVG Volume (30 Days) | 823.3K | ★ 5.8M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.31% |
| EPS Growth | N/A | ★ 46.38 |
| EPS | 0.09 | ★ 0.57 |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $23.58 |
| Revenue Next Year | $26.98 | $8.51 |
| P/E Ratio | $1,224.56 | ★ $23.83 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $9.64 |
| 52 Week High | $126.38 | $15.20 |
| Indicator | CORT | VLY |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 35.88 |
| Support Level | $108.25 | $13.32 |
| Resistance Level | $124.30 | $13.93 |
| Average True Range (ATR) | 5.29 | 0.30 |
| MACD | -0.76 | -0.01 |
| Stochastic Oscillator | 61.04 | 21.94 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.